Cargando…

The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies

Amyloid deposits are insoluble fibrous protein aggregates, identified in numerous diseases, which self-assemble through molecular recognition. This process is facilitated by short amino acid sequences, identified as minimal modules. Peptides corresponding to these motifs can be used for the formatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fichman, Galit, Guterman, Tom, Adler-Abramovich, Lihi, Gazit, Ehud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304689/
https://www.ncbi.nlm.nih.gov/pubmed/28344244
http://dx.doi.org/10.3390/nano4030726
_version_ 1782506928957554688
author Fichman, Galit
Guterman, Tom
Adler-Abramovich, Lihi
Gazit, Ehud
author_facet Fichman, Galit
Guterman, Tom
Adler-Abramovich, Lihi
Gazit, Ehud
author_sort Fichman, Galit
collection PubMed
description Amyloid deposits are insoluble fibrous protein aggregates, identified in numerous diseases, which self-assemble through molecular recognition. This process is facilitated by short amino acid sequences, identified as minimal modules. Peptides corresponding to these motifs can be used for the formation of amyloid-like fibrillar assemblies in vitro. Such assemblies hold broad appeal in nanobiotechnology due to their ordered structure and to their ability to be functionalized. The catechol functional group, present in the non-coded L-3,4-dihydroxyphenylalanine (DOPA) amino acid, can take part in diverse chemical interactions. Moreover, DOPA-incorporated polymers have demonstrated adhesive properties and redox activity. In this work, amyloid-like fibrillar assemblies were formed through the self-assembly of a pentapeptide containing DOPA residues, Asp-DOPA-Asn-Lys-DOPA. The design of this peptide was based on the minimal amyloidogenic recognition motif of the human calcitonin hormone, Asp-Phe-Asn-Lys-Phe, the first amyloidogenic pentapeptide identified. By substituting phenylalanine with DOPA, we obtained DOPA-functionalized amyloid-like assemblies in water. Electron microscopy revealed elongated, linear fibril-like nanometric assemblies. Secondary structure analysis indicated the presence of amyloid-characteristic β-sheet structures as well as random coil structures. Deposition of silver on the DOPA-incorporated assemblies suggested redox activity and demonstrated the applicative potential of this novel nanobiomaterial.
format Online
Article
Text
id pubmed-5304689
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-53046892017-03-21 The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies Fichman, Galit Guterman, Tom Adler-Abramovich, Lihi Gazit, Ehud Nanomaterials (Basel) Article Amyloid deposits are insoluble fibrous protein aggregates, identified in numerous diseases, which self-assemble through molecular recognition. This process is facilitated by short amino acid sequences, identified as minimal modules. Peptides corresponding to these motifs can be used for the formation of amyloid-like fibrillar assemblies in vitro. Such assemblies hold broad appeal in nanobiotechnology due to their ordered structure and to their ability to be functionalized. The catechol functional group, present in the non-coded L-3,4-dihydroxyphenylalanine (DOPA) amino acid, can take part in diverse chemical interactions. Moreover, DOPA-incorporated polymers have demonstrated adhesive properties and redox activity. In this work, amyloid-like fibrillar assemblies were formed through the self-assembly of a pentapeptide containing DOPA residues, Asp-DOPA-Asn-Lys-DOPA. The design of this peptide was based on the minimal amyloidogenic recognition motif of the human calcitonin hormone, Asp-Phe-Asn-Lys-Phe, the first amyloidogenic pentapeptide identified. By substituting phenylalanine with DOPA, we obtained DOPA-functionalized amyloid-like assemblies in water. Electron microscopy revealed elongated, linear fibril-like nanometric assemblies. Secondary structure analysis indicated the presence of amyloid-characteristic β-sheet structures as well as random coil structures. Deposition of silver on the DOPA-incorporated assemblies suggested redox activity and demonstrated the applicative potential of this novel nanobiomaterial. MDPI 2014-08-20 /pmc/articles/PMC5304689/ /pubmed/28344244 http://dx.doi.org/10.3390/nano4030726 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Fichman, Galit
Guterman, Tom
Adler-Abramovich, Lihi
Gazit, Ehud
The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title_full The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title_fullStr The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title_full_unstemmed The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title_short The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
title_sort use of the calcitonin minimal recognition module for the design of dopa-containing fibrillar assemblies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5304689/
https://www.ncbi.nlm.nih.gov/pubmed/28344244
http://dx.doi.org/10.3390/nano4030726
work_keys_str_mv AT fichmangalit theuseofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT gutermantom theuseofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT adlerabramovichlihi theuseofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT gazitehud theuseofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT fichmangalit useofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT gutermantom useofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT adlerabramovichlihi useofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies
AT gazitehud useofthecalcitoninminimalrecognitionmoduleforthedesignofdopacontainingfibrillarassemblies